Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial

Objective To determine whether cognitive therapy is effective in preventing the worsening of emerging psychotic symptoms experienced by help seeking young people deemed to be at risk for serious conditions such as schizophrenia. Design Multisite single blind randomised controlled trial. Setting Diverse services at five UK sites. Participants 288 participants aged 14-35 years (mean 20.74, SD 4.34 years) at high risk of psychosis: 144 were assigned to cognitive therapy plus monitoring of mental state and 144 to monitoring of mental state only. Participants were followed-up for a minimum of 12 months and a maximum of 24 months. Intervention Cognitive therapy (up to 26 (mean 9.1) sessions over six months) plus monitoring of mental state compared with monitoring of mental state only. Main outcome measures Primary outcome was scores on the comprehensive assessment of at risk mental states (CAARMS), which provides a dichotomous transition to psychosis score and ordinal scores for severity of psychotic symptoms and distress. Secondary outcomes included emotional dysfunction and quality of life. Results Transition to psychosis based on intention to treat was analysed using discrete time survival models. Overall, the prevalence of transition was lower than expected (23/288; 8%), with no significant difference between the two groups (proportional odds ratio 0.73, 95% confidence interval 0.32 to 1.68). Changes in severity of symptoms and distress, as well as secondary outcomes, were analysed using random effects regression (analysis of covariance) adjusted for site and baseline symptoms. Distress from psychotic symptoms did not differ (estimated difference at 12 months −3.00, 95% confidence interval −6.95 to 0.94) but their severity was significantly reduced in the group assigned to cognitive therapy (estimated between group effect size at 12 months −3.67, −6.71 to −0.64, P=0.018). Conclusions Cognitive therapy plus monitoring did not significantly reduce transition to psychosis or symptom related distress but reduced the severity of psychotic symptoms in young people at high risk. Most participants in both groups improved over time. The results have important implications for the at risk mental state concept. Trial registration Current Controlled Trials ISRCTN56283883.

[1]  Tyrone D. Cannon,et al.  At clinical high risk for psychosis: outcome for nonconverters. , 2011, The American journal of psychiatry.

[2]  K. Morley,et al.  Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis. , 2011, Archives of general psychiatry.

[3]  G. Dunn,et al.  Estimating dose-response effects in psychological treatment trials: the role of instrumental variables , 2011, Statistical methods in medical research.

[4]  J. van os,et al.  Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. , 2011, Schizophrenia bulletin.

[5]  A. Yung,et al.  Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. , 2011, The Journal of clinical psychiatry.

[6]  Gail M. Williams,et al.  Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. , 2011, Schizophrenia bulletin.

[7]  Ronald Pierson,et al.  Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. , 2011, Archives of general psychiatry.

[8]  Peter B. Jones,et al.  Early detection and intervention evaluation for people at high‐risk of psychosis‐2 (EDIE‐2): trial rationale, design and baseline characteristics , 2011, Early intervention in psychiatry.

[9]  Lu Liu,et al.  A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis , 2011, Schizophrenia Research.

[10]  A. Mack.  Prediction of Psychosis in Adolescents and Young Adults at High Risk: Results From the Prospective European Prediction of Psychosis Study , 2011 .

[11]  J. Os,et al.  Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. , 2011, Schizophrenia bulletin.

[12]  Andreas Meyer-Lindenberg,et al.  Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits , 2010, Nature Neuroscience.

[13]  D. Linszen,et al.  BASELINE DIFFERENCES IN CLINICAL SYMPTOMATOLOGY BETWEEN ULTRA HIGH RISK SUBJECTS WITH AND WITHOUT A TRANSITION TO PSYCHOSIS , 2010, Schizophrenia Research.

[14]  R. Bentall,et al.  DSM‐5 and the ‘Psychosis Risk Syndrome’: Whose best interests would it serve? , 2010 .

[15]  G. Juckel,et al.  Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. , 2010, Archives of general psychiatry.

[16]  D. Freeman,et al.  A randomised controlled trial of a worry intervention for individuals with persistent persecutory delusions , 2010, Journal of behavior therapy and experimental psychiatry.

[17]  A. Mackinnon,et al.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. , 2010, Archives of general psychiatry.

[18]  J. Moncrieff,et al.  A systematic review of the effects of antipsychotic drugs on brain volume , 2010, Psychological Medicine.

[19]  G. Andersson,et al.  The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size , 2009, Psychological Medicine.

[20]  D. Linszen,et al.  Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis , 2009, Schizophrenia Research.

[21]  S. Bucci,et al.  Therapist treatment adherence in CBT for people at ultra-high risk for psychosis: Development of a new rating scale. , 2008 .

[22]  P. McGorry,et al.  Non-pharmacological management of antipsychotic-induced weight gain: Systematic review and meta-analysis of randomised controlled trials , 2008, British Journal of Psychiatry.

[23]  J. Os,et al.  A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder , 2008, Psychological Medicine.

[24]  B. Everitt,et al.  Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor , 2007, Schizophrenia bulletin.

[25]  Tyrone D. Cannon,et al.  Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. , 2008, Archives of general psychiatry.

[26]  A. Yung,et al.  Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis , 2007, Schizophrenia Research.

[27]  Tyrone D. Cannon,et al.  Self-report of attenuated psychotic experiences in a college population , 2007, Schizophrenia Research.

[28]  A. Yung,et al.  Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? , 2007, Schizophrenia bulletin.

[29]  R. Bentall,et al.  Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk. , 2007, Schizophrenia bulletin.

[30]  John D. Ainsworth,et al.  The PsyGrid Experience: Using Web Services in the Study of Schizophrenia , 2007, Int. J. Heal. Inf. Syst. Informatics.

[31]  I. Hickie,et al.  Clinical Staging of Psychiatric Disorders: A Heuristic Framework for Choosing Earlier, Safer and more Effective Interventions , 2006, The Australian and New Zealand journal of psychiatry.

[32]  Adrian Preda,et al.  Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. , 2006, The American journal of psychiatry.

[33]  A. Yung,et al.  Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States , 2005 .

[34]  Jeffrey A. Lieberman,et al.  International clinical practice guidelines for early psychosis , 2005, British Journal of Psychiatry.

[35]  R. Bentall,et al.  Cognitive therapy for the prevention of psychosis in people at ultra-high risk , 2004, British Journal of Psychiatry.

[36]  A. Morrison,et al.  Early Detection and Cognitive Therapy for People at High Risk of Developing Psychosis: A Treatment Approach , 2004 .

[37]  G. Patton,et al.  Monitoring and Care of Young People at Incipient Risk of Psychosis , 2004 .

[38]  J. van Os.  Is there a continuum of psychotic experiences in the general population? , 2003, Epidemiology and Psychiatric Sciences.

[39]  Nicole A. Lazar,et al.  Statistical Analysis With Missing Data , 2003, Technometrics.

[40]  A. Yung,et al.  Mapping the onset of psychosis: The comprehensive assessment of at risk mental states (CAARMS) , 2003, Schizophrenia Research.

[41]  Eric R. Ziegel,et al.  Applied Multivariate Data Analysis , 2002, Technometrics.

[42]  Hok Pan Yuen,et al.  Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. , 2002, Archives of general psychiatry.

[43]  R. Bentall,et al.  Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals , 2002, British Journal of Psychiatry.

[44]  A. Vergouwen,et al.  Patient adherence with antidepressant treatment. , 2002, The British journal of psychiatry : the journal of mental science.

[45]  B. Kupelnick,et al.  Patient adherence with antidepressant treatment. Authors' reply , 2002 .

[46]  R. Bentall,et al.  Randomised controlled trial of early detection , 2002 .

[47]  I. Blackburn,et al.  THE REVISED COGNITIVE THERAPY SCALE (CTS-R): PSYCHOMETRIC PROPERTIES , 2001 .

[48]  A. Morrison.  THE INTERPRETATION OF INTRUSIONS IN PSYCHOSIS: AN INTEGRATIVE COGNITIVE APPROACH TO HALLUCINATIONS AND DELUSIONS , 2001, Behavioural and Cognitive Psychotherapy.

[49]  L. Peters.  Discriminant validity of the Social Phobia and Anxiety Inventory (SPAI), the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). , 2000, Behaviour research and therapy.

[50]  N. Nagelkerke,et al.  Estimating treatment effects in randomized clinical trials in the presence of non-compliance. , 2000, Statistics in medicine.

[51]  T. Sensky,et al.  A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication. , 2000, Archives of general psychiatry.

[52]  S. Evans,et al.  Application and Results of the Manchester Short Assessment of Quality of Life (Mansa) , 1999, The International journal of social psychiatry.

[53]  N. Tarrier,et al.  Randomised controlled trial of intensive cognitive behaviour therapy for patients with chronic schizophrenia , 1998, BMJ.

[54]  R. Mattick,et al.  Development and validation of measures of social phobia scrutiny fear and social interaction anxiety. , 1998, Behaviour research and therapy.

[55]  A. Beck,et al.  Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. , 1997, Behaviour research and therapy.

[56]  G C Patton,et al.  Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.

[57]  M. Birchwood.  Early Intervention in Psychotic Relapse: Cognitive Approaches to Detection and Management , 1995, Behaviour Change.

[58]  P. Salkovskis,et al.  A Comparison of Cognitive Therapy, Applied Relaxation and Imipramine in the Treatment of Panic Disorder , 1994, British Journal of Psychiatry.

[59]  B. Everitt,et al.  Applied Multivariate Data Analysis. , 1993 .

[60]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[61]  J. Hausman.  Specification tests in econometrics , 1978 .